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ABBREVIATION LIST 35 
ANOVA – Analysis of variance 36 
ATP – Adenosine triphosphate 37 
BMI – Body mass index 38 
CON – Concentric cycling 39 
COPD – Chronic obstructive pulmonary disease 40 
Cr – Creatine 41 
DOMS – Delayed onset muscle soreness 42 
ECC – Eccentric cycling 43 
EMG – Electromyography  44 
HR – Heart rate 45 
PCr – Phosphocreatine 46 
PR – Pulmonary rehabilitation 47 
RER – Respiratory exchange ratio 48 
V̇CO2 – Carbon dioxide production 49 
VE – Minute ventilation 50 
V̇O2 – Oxygen uptake 51 
V̇O2peak – Oxygen uptake at peak exercise  52 
Wpeak – Workload at peak exercise 53 





Background: Eccentric cycling (ECC) may be an attractive exercise modality in COPD due to both low 57 
cardiorespiratory demand and perception of effort compared to conventional concentric cycling 58 
(CON) at matched mechanical loads. However, it is unknown whether ECC can be performed by 59 
individuals with COPD at an intensity able to cause sufficient metabolic stress to improve aerobic 60 
capacity. 61 
Research question: What are the cardiopulmonary and metabolic responses to ECC in people with 62 
COPD and healthy volunteers when compared to CON at matched mechanical loads? 63 
Study Design and Methods: 13 individuals with COPD (mean ± SD age 64 ± 9 years, FEV1 %pred 45 ± 64 
19%, BMI 24 ± 4 kg.m-2, V̇O2peak 15 ± 3 ml.kg-1.min-1) and 9 age matched controls (FEV1 %pred 102 ± 65 
13%, BMI 28 ± 5 kg.m-2, V̇O2peak 23 ± 5 ml.kg-1.min-1), performed up to six 4 min bouts of ECC and CON 66 
at matched mechanical loads of increasing intensity. In addition, 12 individuals with COPD 67 
underwent quadriceps muscle biopsies before and after 20 min of ECC and CON at 65% peak power.  68 
Results: At matched mechanical loads, oxygen uptake, minute ventilation, heart rate, systolic blood 69 
pressure, RER (all p<0.001), capillary lactate, perceived breathlessness and leg fatigue (p<0.05) were 70 
lower in both groups during ECC than CON. Muscle lactate content increased (p=0.008), and muscle 71 
phosphocreatine decreased (p=0.012) during CON in COPD, which was not evident during ECC.  72 
Interpretation: Cardiopulmonary and blood lactate responses during submaximal ECC were less 73 
compared to CON at equivalent mechanical workloads in health and COPD, and this was confirmed 74 
at a muscle level in COPD. Submaximal ECC was well tolerated and allowed greater mechanical work 75 
at lower ventilatory cost. However, in people with COPD, a training intervention based on ECC is 76 
unlikely to stimulate cardiovascular and metabolic adaptation to the same extent as CON. 77 
 78 
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Exercise training, as part of pulmonary rehabilitation (PR), is an effective treatment for people with 80 
COPD, improving quality of life, breathlessness and exercise capacity1. However, there is significant 81 
variation in the response between individuals2 and some patients, particularly those with more 82 
severe disease3, are unable to achieve the maximum gain from PR, suggesting the need for novel 83 
exercise training modalities targeting these populations. Eccentric exercise (ECC), involving muscle 84 
contraction during active lengthening, is one such strategy that might address this need.  85 
Most individuals with moderate or severe COPD stop exercising prematurely due to abnormal 86 
ventilatory mechanics4, thereby limiting exercise intensity and lessening the potential benefits of 87 
exercise training. ECC, in comparison to traditional concentric exercise (CON), is known to result in a 88 
lower whole-body cardiopulmonary demand at matched mechanical loads5. It may therefore be 89 
highly appropriate for use in COPD, allowing either higher muscle workloads than CON to be 90 
achieved or increased comfort through lower perceived dyspnoea at equivalent muscle workloads6. 91 
Historically, ECC was avoided due to the propensity to cause delayed onset muscle soreness (DOMS) 92 
in unaccustomed muscle, particularly at high exercise workloads7. However, it is now apparent that 93 
ECC can be safely performed without the occurrence of DOMS, including in disease populations such 94 
as those with COPD8, if the workload is gradually increased over several exercise sessions9.  95 
Despite the knowledge that ECC is safe for individuals with COPD, the quantification of 96 
cardiopulmonary responses during ECC for people with COPD and the implication for aerobic 97 
adaptation is unclear. Previous research into the cardiopulmonary responses to ECC in people with 98 
COPD has been limited to low mechanical loads10 such that the responses across a range of 99 
workloads and comparison with age matched controls have not been investigated. Furthermore, the 100 
muscle level metabolic response to ECC in comparison to CON at an equivalent mechanical load has 101 
not been investigated in COPD. This is important because the magnitude of the metabolic stress 102 
generated is highly likely to dictate the magnitude of metabolic adaptation if prolonged ECC was 103 
used as a training strategy. 104 
We therefore aimed to 1) quantify the relationship between mechanical load and whole-body 105 
cardiopulmonary responses during ECC in comparison to CON in individuals with COPD and age 106 
matched healthy volunteers and 2) determine the muscle level metabolic response of submaximal 107 
ECC in comparison to CON for people with COPD. Finally, as part of the study participants were 108 







Full details of recruitment and eligibility criteria can be found in the online supplement (e-Appendix 114 
1). In brief, participants aged over 40 with COPD (FEV1/FVC <0.7), FEV1 ≤ 60% predicted and Medical 115 
Research Council (MRC) dyspnoea scale ≥3 and BMI<35 were recruited. In addition, healthy controls 116 
aged over 40 free from major illness impairing exercise capacity, without airflow limitation 117 
(FEV1/FVC ≥0.7) or significant breathlessness (MRC ≤2) were recruited. 118 
Study design 119 
Participants with COPD and age matched healthy volunteers performed up to six 4 min bouts of ECC 120 
and CON at increasing, matched mechanical loads with a 4-minute rest between bouts (Figure 1). 121 
The first bout was performed at 15% of peak workload (Wpeak) obtained from a maximal concentric 122 
incremental ramp test at baseline with intensity increasing by 15% Wpeak for each bout until the 123 
participant reached 90% Wmax or was unable to continue due to volitional exhaustion (e-Figure 1). 124 
Expired gas analysis and heart rate (HR) monitoring was performed throughout, blood pressure 125 
measured once per stage and capillary lactate measured during the final 10s of each stage.  126 
The same protocol was repeated in ECC at matched mechanical loads during a separate study visit at 127 
least one week later. Four-minute bouts were chosen to allow sufficient time for a steady state in 128 
physiological parameters to be achieved whilst minimising the effect of fatigue. A subgroup of 129 
participants with COPD consented to needle muscle biopsies (vastus lateralis) taken at separate 130 
visits before and after 20 min (or until volitional exhaustion) of CON and ECC at matched mechanical 131 
load at 65% concentric Wpeak.  132 
ECC familiarisation was performed on three occasions for 10, 15 and 15 min at increasing relative 133 
workloads (10 min at 15% Wpeak in visit 1, 5 min at 15% Wpeak and 10 min at 45% Wpeak in visit 2 and 5 134 
min at 45% Wpeak and 10 min at 60% Wpeak in visit 3). These familiarisations were performed at the 135 
end of the first three laboratory visits following CON tests. Following completion of the study, 136 
participants were asked to complete a questionnaire exploring the perceptual aspects of ECC. This 137 
questionnaire was developed during pilot testing and was specific to our study design (e-Appendix 138 
2). 139 
The protocol was approved by the Leicestershire South Regional Ethics Committee (IRAS 214536). All 140 
participants gave informed written consent prior to taking part. Separate informed written consent 141 
was obtained for biopsy sampling.  142 
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All cycling tests were performed on a commercially available upright ergometer able to switch 143 
between concentric and eccentric modes (Lode Corival Eccentric, Lode, Netherlands). This is a 144 
traditional electrically braked upright ergometer, modified by the addition of a motor which, when 145 
engaged during ECC mode, applies constant torque to drive the pedals in reverse. The participant 146 
aims to slow down the movement of the pedals, targeting the desired speed. A target of 60 rpm was 147 
used for all CON and ECC tests. 148 
Cardiopulmonary exercise testing 149 
Following a 3 min warm up period, participants cycled concentrically at increasingly mechanical load 150 
(ramp protocol 5-10 W.min-1) until volitional exhaustion. Participants were asked to cycle at 60 rpm, 151 
and test end was defined as the point at which the cadence dropped below 50 rpm for 10s. Peak 152 
oxygen uptake (V̇O2peak) was defined as the peak value of rolling 30s averages of VO211. Maximal 153 
verbal encouragement was given, and all tests were supervised by the same investigator (TW).  154 
Expiratory gas analysis and HR were recorded using a CareFusion metabolic cart (San Diego, United 155 
States). The volume and gas analysers were calibrated before each test using a 3-litre syringe and a 156 
known concentration of gas (4.99% CO2, 15.99% O2). The modified Borg scale12 was used to measure 157 
leg fatigue and breathlessness during exercise.  158 
Capillary blood sampling 159 
Earlobe capillary blood was analysed immediately following sampling for lactate and glucose 160 
concentration using an enzymatic assay (Biosen S-line point of care analyser, EKF diagnostics, 161 
Germany). Calibration was performed before each use against a standard solution. Where the 162 
analyser gave a unrecordable low reading for lactate, the lower limit of detection (0.5 mmol.l-1) was 163 
included in the analysis.  164 
Muscle biopsies  165 
Individuals with COPD were invited to take part in an optional addition to the study in which vastus 166 
lateralis biopsies were performed before and after exercise. Participants performed 20 min bouts of 167 
ECC and CON at 65% Wpeak at separate study visits at least one week apart and biopsies were taken 168 
at rest and 60s after exercise cessation from incisions at least 2 cm apart. Biopsies for ECC and CON 169 
conditions were obtained from opposite legs. CON bouts were performed first and if 20 min was not 170 
achieved (4 out of 12 participants), biopsies were taken at the end of exercise and matched time was 171 
performed during ECC. Approximately 100 mg of tissue was removed under local anaesthetic using 172 
the modified Bergstrom technique13. Tissue was immediately frozen in liquid nitrogen and stored at -173 
80°C until analysis.  174 
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Muscle tissue analysis 175 
Samples of approximately 50 mg wet weight were cut, freeze-dried then powdered by hand with 176 
removal of visible blood and connective tissue. 4-10 mg of powdered tissue was extracted using 0.5 177 
mmol.l-1 perchloric acid containing 0.1 mmol.l-1 EDTA. Following mixing and centrifugation, the 178 
supernatant was recovered and neutralised with 2.2 mmol.l-1 potassium bicarbonate. The sample 179 
was again spun down, and the supernatant extracted for analysis. Muscle tissue was analysed for 180 
phosphocreatine (PCr), creatine (Cr), adenosine triphosphate (ATP) and lactate using a modification 181 
of the spectrophotometric method of Harris et al14. For muscle ATP, PCr and Cr, values were 182 
normalised against the highest total creatine content (PCr+Cr) for that individual to correct for 183 
differences in non-muscle constituents between biopsy samples15. 184 
Statistical analysis 185 
Full details of statistical analysis methods can be found in e-Appendix 3. 186 
We performed a sample size calculation based on an alpha value of 0.05 and a beta value of 0.2 187 
which identified a required sample size of 6 (full details in e-Appendix 3). Cardiorespiratory and 188 
metabolic parameters during CON and ECC tests were compared using linear mixed models. 189 
Individual comparisons between CON and ECC at specific time points within groups were performed 190 
with Bonferroni corrections for multiple comparisons. For non-parametric data we used the 191 
Wilcoxon signed-rank test and the Mann-Whitney U test for repeated and independent data 192 
respectively. For all comparisons, a 5% significance level was used (p<0.05). 193 
 194 
Results 195 
Initially, 15 patients with COPD and 10 healthy volunteers were recruited. One healthy volunteer 196 
was excluded due to uncontrolled hypertension and one COPD patient was excluded due to severe 197 
exercise induced desaturation. One further COPD patients withdrew after the initial assessment, 198 
without giving a reason, therefore 13 COPD patients and 9 healthy volunteers entered the study (e-199 
Figure 2).  200 
From this initial cohort, fewer than expected participants consented to muscle biopsies and 201 
therefore six additional individuals with COPD were recruited for an abridged study and had muscle 202 
biopsies taken before and after 20 min bouts of CON and ECC but did not perform the repeated 4 203 
min bouts of CON and ECC. Data from these two cohorts is presented separately (Table 1). 204 
Concentric and eccentric 4-minute bouts 205 
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In the COPD cohort, five participants were unable to complete the higher load CON bouts due to 206 
volitional exhaustion. Completers and non-completers showed no significant differences except in 207 
BMI; completers had a higher BMI than non-completers (26 vs 21 kg.m-2, p<0.05). All participants 208 
were able to complete six 4 min bouts of ECC and all healthy volunteers completed six 4 min bouts 209 
of CON. Absolute workload performed during bouts is shown in e-Table 2. 210 
V̇O2 (Figure 2, e-Table 1), HR, VE, capillary lactate concentration (Figure 3), systolic blood pressure, 211 
V̇CO2 and RER (e-Figure 3) were all significantly lower during ECC than CON for both COPD and 212 
healthy control groups (all p<0.001). At higher workloads, perceived leg fatigue was lower during 213 
ECC than CON and perceived breathlessness during ECC minimal in both groups (p<0.01 from 60% 214 
Wpeak stage onwards, Figure 3). The gradient of the slope of the V̇O2 (ml.min-1): Power (Watts) 215 
relationship during ECC was 2.8-fold and 3.3-fold lower than CON for the COPD and control groups 216 
respectively. There was a significant group by exercise mode by time interaction for V̇O2, V̇CO2, HR, 217 
VE and capillary lactate (all p<0.003) therefore, the ratio of these parameters between CON and ECC 218 
was different between groups.  219 
Muscle metabolites 220 
Of the 12 participants with COPD consenting to vastus lateralis biopsies before and after 20 min of 221 
continuous CON and ECC, three withdrew consent after the CON visit and declined biopsies before 222 
and after ECC. A further four participants had unusable tissue samples for the post CON timepoint. 223 
There were therefore 12 biopsy samples at rest pre-CON, 8 post CON exercise samples and 9 224 
samples pre and post ECC. Linear mixed model analysis was utilised to allow for missing data. 225 
There was no difference in ATP concentration between timepoints or between modalities (p=0.51, 226 
Figure 4a). There were significant exercise modality by timepoint interactions for PCr, Cr and lactate 227 
(p=0.001, p<0.001 and p=0.002 respectively, Figure 4b-d) indicating a rise in lactate and a conversion 228 
from phosphocreatine to creatine after CON but no change from baseline following ECC. 229 
Experience of eccentric cycling 230 
In comparison to the healthy control group, a greater proportion of the COPD group preferred ECC 231 
to CON (76% vs. 22%, p=0.01, Figure 5h). Greater enjoyment was seen during ECC than CON for the 232 
COPD group (p=0.004, Figure 5a&b) with no difference seen for healthy controls (p=0.68). Both 233 
groups found ECC and CON equally challenging (p=0.1, Figure 5c). A majority (65% of the COPD 234 
group and 56% of the healthy control group) found ECC easy to get used to with no significant 235 
difference between groups (p=0.46, Figure 5e). When asked whether they would like to do more 236 
ECC, there was greater agreement in the COPD than the healthy control group (94% vs 56% p=0.01, 237 
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Figure 5f). Most participants in both groups thought ECC would improve their fitness with no 238 
difference between groups (65% and 89% in COPD and control groups respectively, p=0.71, Figure 239 
5g).  240 
 241 
Discussion 242 
This study is the first to describe the physiological responses to ECC across a range of submaximal 243 
mechanical workloads in people with COPD in comparison to age matched controls. We have 244 
demonstrated that, in direct contrast to CON, there are minimal increases in V̇O2 and VE during 245 
submaximal ECC even at higher relative workloads in both COPD and health, and this is associated 246 
with lower perceived breathlessness and leg fatigue at matched mechanical loads compared with 247 
CON. Moreover, this was accompanied by the complete lack of muscle lactate accumulation and PCr 248 
degradation in the quadriceps during ECC at a fixed submaximal workload in individuals with COPD. 249 
Collectively these findings demonstrate that although perception of effort and fatigue were 250 
positively influenced by ECC, this exercise modality elicited minimal cardiorespiratory and muscle 251 
metabolic stress in healthy volunteers and COPD patients and is therefore less likely to be an 252 
effective modality for increasing aerobic capacity in individuals with COPD.  253 
In health, ECC results in lower oxygen demand than CON with the ratio of V̇O2 between CON and ECC 254 
at matched mechanical power quoted as between 1.5-516,17. There has been limited previous 255 
research on cardiorespiratory parameters during ECC for people with COPD. Rooyackers and 256 
colleagues investigated 12 individuals with COPD performing 6 min constant load tests of ECC and 257 
CON at 25% and 50% of Wpeak10. They found lower V̇O2, V̇CO2 and VE during ECC than CON although 258 
HR and perception of effort were similar between modalities. However, this study was limited to low 259 
mechanical loads and therefore was unable to detect differences evident at higher loads. Lower V̇O2 260 
and VE has also been demonstrated for individuals with COPD performing downhill walking as 261 
compared to level walking18. Our study adds to previous research by quantifying several 262 
cardiopulmonary parameters across a range of matched workloads in comparison to CON. 263 
Previous evaluation of the muscle metabolic response to ECC has been limited to healthy 264 
individuals19 and this is the first study to our knowledge to study the metabolic response to ECC in 265 
people with COPD. In healthy subjects, Bonde-Peterson et al19 demonstrated no change in muscle 266 
ATP, Cr, glycogen and lactate concentration following relatively high intensity ECC, in contrast to 267 
CON which induced a decline in muscle PCr and glycogen, and a rise in lactate concentration.  268 
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An increase in the muscle lactate and creatine content and a decline in muscle PCr following CON, 269 
has previously been demonstrated in COPD20 and was confirmed in our study indicating that a 270 
measurable increase in non-mitochondrial ATP production occurred despite low absolute exercise 271 
workloads21.  The complete absence of such metabolic stress during ECC demonstrates that muscle 272 
energy requirement was measurably less than CON and the lower muscle ATP demand could be 273 
wholly met by mitochondrial ATP generation22.  274 
MacMillan and colleagues performed muscle biopsies on patients with COPD after a 10-week 275 
progressive ECC cycling training programme and a control group performing CON cycling training at a 276 
quarter of the mechanical load23. They found an increase in peak strength and muscle mass 277 
following ECC training without an increase in fibre cross sectional area. An improvement in oxidative 278 
capacity was only seen in the CON group suggesting that the lack of muscle metabolic response seen 279 
in our study is likely to result in diminished metabolic adaptation following prolonged ECC training, 280 
even at high submaximal mechanical loads. However, the work of Bourbeau and colleagues 281 
demonstrates that ECC training results in greater improvements in muscle strength than CON at a 282 
matched cardiopulmonary load with similar improvements seen in cycling performance24 and 283 
therefore functional adaptation may occur without improvements in metabolic adaptation . Indeed, 284 
the activation of skeletal muscle signalling pathways related to protein synthesis and changes in 285 
mRNA expression linked to muscle regeneration/degradation has been observed following repeated 286 
bouts of eccentric cycling25. 287 
ECC resulted in minimal breathlessness in both healthy volunteers and those with COPD, even at 288 
higher mechanical loads, unsurprising given the low cardiorespiratory response demonstrated. What 289 
is perhaps more surprising, is that ECC elicits lower leg fatigue than CON at matched mechanical 290 
loads which could be explained by lower muscle fibre activation during ECC with lower EMG activity 291 
for the same force production as CON26. Eccentric and concentric cycling were found to be equally 292 
challenging although the challenges of eccentric cycling, including the concentration required and 293 
the difficulty getting used to the technique, appear different from the exertional challenges of 294 
concentric cycling.  295 
The lower effort required for ECC results appears to result in greater popularity of ECC than CON for 296 
individuals with COPD suggesting that ECC would be well received in a PR setting and might be useful 297 
in improving participation and completion of PR. Patients often cite a belief that exercise is beyond 298 
their capabilities as a reason for not attending PR27 and therefore eccentric cycling could be used as 299 
a motivational technique whilst allowing initial muscle remodelling prior to the initiation of 300 




This study was limited to a small number of individuals, and variation, particularly within the 303 
heterogeneity of COPD, could not be explored. We prescribed mechanical load based on CON peak 304 
power and this is likely to have only moderate correlation with peak eccentric strength28. Mechanical 305 
load was matched to allow direct comparison of ECC and CON modalities, and although CON was 306 
performed to exhaustion, participants could have performed significantly higher loads eccentrically. 307 
However, we did not feel that an ECC test to exhaustion was ethically justifiable, particularly in an 308 
older, relatively frail population as the risk of severe DOMS, muscle damage and functional 309 
impairment would have been unacceptably high. Participants were required to attend the laboratory 310 
on five separate occasions which may cause a significant burden particularly for individuals with 311 
COPD. 312 
ECC training at matched cardiopulmonary load to CON might theoretically allow similar 313 
improvements in aerobic capacity but greater improvements in muscle strength. However our study 314 
did not include any CON and ECC bouts at matched cardiopulmonary load. Failure of co-ordination 315 
during ECC on an upright ergometer, such as the one used in this study, appears to limit the high 316 
loads required to elicit a significant metabolic response29 whereas the same seems not to be true on 317 
a recumbent ergometer23. 318 
For the muscle metabolite analysis, we have only studied one mechanical workload and it may be 319 
that higher eccentric loads would demonstrate greater muscle metabolic demand. However, the 320 
results of the parameters demonstrated in the repeated 4 min bouts, particularly the absence of a 321 
rise in capillary lactate, suggest that this is unlikely. The cohorts consenting for muscle biopsies and 322 
performing repeated four-minute bouts of ECC and CON were different and may have had different 323 
baseline characteristics. 324 
We have demonstrated that most participants with COPD preferred ECC to CON. However, these 325 
were participants who had volunteered for a research study involving a novel exercise modality and 326 
therefore may be biased to select the novel exercise as preferable.  327 
Potential implications and future work 328 
These results suggest that ECC training, although allowing exercise at reduced ventilatory cost and 329 
improved comfort may not be able to achieve the same gains in cardiorespiratory and metabolic 330 
adaptation as CON. However, despite the low cardiometabolic demand of ECC, it may still have a 331 
role in the treatment of COPD. A potential mechanism for ECC to increase endurance capacity, which 332 
has been showed to be possible in cardiac populations30–32, may be through dyspnoea 333 
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desensitisation or improved mechanical efficiency, allowing greater workloads to be performed prior 334 
to exercise cessation. We know ECC can improve muscle size and strength, particularly eccentric 335 
strength which may be associated with reduced falls risk33. Furthermore, the popularity of ECC, 336 
might improve participation and completion of pulmonary rehabilitation. The focus of ECC training in 337 
clinical populations should perhaps be on enhanced gains in muscle mass and strength with the 338 
acceptance that training which overloads the metabolic capacity of the muscle must be performed in 339 
addition if the goal is to improve aerobic capacity. 340 
In summary, this study demonstrates that the low cardiopulmonary demand of ECC when compared 341 
to CON at matched mechanical loads previously demonstrated in healthy individuals is also seen in 342 
individuals with COPD and appears not to be affected by COPD diagnosis. The metabolic demand of 343 
ECC on the exercising muscle for people with COPD appears to be minimal with no detectable 344 
change in the intramuscular metabolites measured. ECC causes minimal perceived breathlessness 345 
and is popular with people with COPD with most preferring it to traditional CON. These findings have 346 
implications for the role of ECC in pulmonary rehabilitation and suggest that ECC is unlikely to result 347 
in muscle aerobic adaptation but may allow muscle size and strength adaptation whilst improving 348 
the comfort of exercise training for people with COPD. 349 
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Table 1 – MRC: medical research council dyspnoea scale, BMI: body mass index, V̇O2peak: oxygen uptake at 452 
peak concentric exercise, Wpeak: peak concentric workload. Mean ± SD or Median (IQR). *Difference from 453 
healthy control group p<0.05 454 
 455 
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Figure legends 457 
Figure 1 – Study diagram. Healthy volunteers and some participants with COPD performed the full study 458 
without muscle biopsies but data for these participants from visits 3 and 5 are not presented. Fewer 459 
participants than expected consented for muscle biopsies and therefore further COPD patients were recruited 460 
for an abridged study and performed only visits 1, 3 and 5. CON: concentric cycling, ECC: eccentric cycling. 461 
Figure 2 – Oxygen uptake (V̇O2) during concentric and eccentric cycling, CON: concentric cycling, ECC: eccentric 462 
cycling, Wpeak: peak concentric workload. Absolute workload performed during bouts is shown in e-Table 2. 463 
Mean ± SEM *p<0.001 COPD CON vs ECC, ⱡp<0.001 Healthy controls CON vs ECC. ¶p<0.05 between groups. 464 
Figure 3 – Cardiorespiratory parameters during 4 min bouts of concentric and eccentric cycling at matched 465 
mechanical load in individuals with COPD and age matched healthy controls. a) minute ventilation (VE), b) tidal 466 
volume (VT), c) respiratory rate, d) capillary lactate concentration, e) heart rate, f) perceived breathlessness, g) 467 
perceived leg fatigue. CON: concentric cycling, ECC: eccentric cycling, Wpeak: peak concentric workload. 468 
Absolute workload performed during bouts is shown in e-Table 2. Mean ± SEM or Median ± IQR. *p<0.05 COPD 469 
CON vs ECC, ⱡp<0.05 Healthy controls CON vs ECC, ¶p<0.05 between groups. 470 
Figure 4 – Metabolite concentration in vastus lateralis biopsies from COPD patients before and after 471 
continuous bouts of concentric (CON) and eccentric (ECC) cycling at matched mechanical load of 65% peak 472 
power. a) adenosine triphosphate (ATP), b) phosphocreatine, c) creatine, d) lactate. Mean ± SEM, *p<0.05. 473 
Figure 5 – Experience of eccentric cycling for individuals with COPD and healthy controls (HC) – results from 474 




Table 1 – participant demographics 477 
  
Participants performing repeated  




muscle biopsies  
COPD (n=13) 




Age (years) 64 ± 9.4 64 ± 8.8 67 ± 10 
Gender (M:F) 8:5 6:3 7:5 
Current smoker (%) 15 11 17 
Smoking history (pack years) 55 ± 38* 10 ± 15 62 ± 38 
MRC dyspnoea score 3 (3-4)* 1 (1-1) 3 (3-3) 
Height (cm) 167 ± 10 171 ± 7 168 ± 9 
Weight (kg) 68 ± 15 81 ± 16 75 ± 14 
BMI (kg.m-2) 24.2 ± 4.5 27.7 ± 4.8 26.7 ± 4.5 
FEV1 (L) 1.12 ± 0.6* 2.88 ± 0.4 1.2 ± 0.4 
FEV1 (% pred) 45 ± 19* 102 ± 13 48 ± 19 
FVC (L) 2.7 ± 1* 3.9 ± 0.6 2.6 ± 0.7 
FVC (% pred) 81 ± 23* 110 ± 14 81 ± 22 
FEV1/FVC 0.44 ± 0.13* 0.74 ± 0.04 0.47 ± 0.14 
V̇O2peak (ml.min-1) 1019 ± 343* 1867 ± 394 1158 ± 333 
V̇O2peak (ml.kg-1.min-1) 15.0 ± 3.2* 23.3 ± 4.6 15.4 ± 2.9 
Peak workload (W) 69 ± 35* 147 ± 24 80 ± 30 




Breathlessness 67%* 22% 67% 
Leg fatigue 17% 67% 17% 
Breathlessness 
and leg fatigue 
17% 11% 17% 
 478 
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